Recently, a subsidiary of Tai Ai Peptide Group was recognized as a National High-Tech Enterprise, receiving the “High-Tech Enterprise Certificate” jointly issued by the Ministry of Science and Technology, the Ministry of Finance, and the State Administration of Taxation. This is another authoritative national recognition of the Group’s technological innovation and overall corporate strength, following its achievements in obtaining multiple national invention patents and leading market sales.
As a company deeply rooted in the peptide health field, Taiai Peptide Group has always adhered to the development philosophy of “technology-driven health.” The Group has built a complete research and development system covering raw material research and development, process innovation, and product application, and has established industry-university-research cooperation mechanisms with many universities and research institutions.
This recognition as a high-tech enterprise is not only an affirmation of Tai Ai Peptide’s technological innovation capabilities, but will also bring policy support to the group in areas such as R&D and scientific research project applications. Ms. Wu Xia, Chairman of the Board, stated, “The certificate is an honor, but more importantly, it is a responsibility. Tai Ai Peptide will continue to increase its R&D investment, focusing on technological breakthroughs and application innovations in the field of biopeptides, to serve the health needs of global consumers with higher-quality products and contribute to the implementation of the Healthy China strategy.”
Post time: Feb-11-2026